UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Prevents HBV Reactivation with Tenofovir in Anti-HBC Positive Patients with Hematologic Malignancies Treated with Rituximab. Results Final Visit 18-Months (Preblin Study)

Journal of hepatology, 2016, Vol.64 (2), p.S369-S369

2016

Volltextzugriff (PDF)

Clinical outcomes of patients delisted from the waiting list of liver transplantation after interferon-free antiviral therapy

Journal of hepatology, 2017, Vol.66 (1), p.S186-S186

2017

Volltextzugriff (PDF)

P887 POST LIVER TRANSPLANTATION PROPHYLAXIS OF HEPATITIS B RECURRENCE WITH NUCLEOS(T)IDE ANALOG THERAPY FOLLOWING HEPATITIS B IMMUNOGLOBULIN DISCONTINUATION

Journal of hepatology, 2014-04, Vol.60 (1), p.S370-S370

2014

Volltextzugriff (PDF)

Decreasing the Risk of HCC in Caucasian Chronic Hepatitis B Patients under NUCS: Results of the Spanish Chronic Hepatitis B Registry (Ciberhep)

Journal of hepatology, 2016, Vol.64 (2), p.S324-S325

2016

Volltextzugriff (PDF)

Interferon (INF)-Free Antiviral Therapy in Cirrhotic Patients Infected with Hepatitis C on the Waiting List for Liver Transplantation. Efficacy and Impact on Delisting and Liver Function

Journal of hepatology, 2016, Vol.64 (2), p.S543-S543

2016

Volltextzugriff (PDF)

P1040 TENOFOVIR FOR THE PROPHYLAXIS OF HBV REACTIVATION IN ANTI-HBC-POSITIVE PATIENTS WITH HEMATOLOGIC MALIGNANCIES TREATED WITH RITUXIMAB: PRELIMINARY RESULTS OF A RANDOMIZED STUDY (PREBLIN STUDY)

Journal of hepatology, 2014-04, Vol.60 (1), p.S421-S422

2014

Volltextzugriff (PDF)

P1058 LONG-TERM EFFICACY OF TENOFOVIR IN PREVIOUSLY TREATED AND NAIVE PATIENTS. RESULTS FROM THE SPANISH CHRONIC HEPATITIS B REGISTRY (CIBERHEP)

Journal of hepatology, 2014-04, Vol.60 (1), p.S429-S429

2014

Volltextzugriff (PDF)

194 RISK-FACTORS ASSOCIATED WITH THE DEVELOPMENT OF CHRONIC REJECTION DURING ANTIVIRAL THERAPY OF POST-TRANSPLANT RECURRENT HEPATITIS C: A PROSPECTIVE STUDY

Journal of hepatology, 2008, Vol.48, p.S81-S82

2008

Volltextzugriff (PDF)

THU-139 - Prevents HBV Reactivation with Tenofovir in Anti-HBC Positive Patients with Hematologic Malignancies Treated with Rituximab. Results Final Visit 18-Months (Preblin Study)

Journal of hepatology, 2016, Vol.64 (2), p.S369-S369

2016

Volltextzugriff (PDF)

THU-431 - Clinical outcomes of patients delisted from the waiting list of liver transplantation after interferon-free antiviral therapy

Journal of hepatology, 2017, Vol.66 (1), p.S186-S186

2017

Volltextzugriff (PDF)

FRI-464 - Interferon (INF)-Free Antiviral Therapy in Cirrhotic Patients Infected with Hepatitis C on the Waiting List for Liver Transplantation. Efficacy and Impact on Delisting and Liver Function

Journal of hepatology, 2016, Vol.64 (2), p.S543-S543

2016

Volltextzugriff (PDF)

THU-056 - Decreasing the Risk of HCC in Caucasian Chronic Hepatitis B Patients under NUCS: Results of the Spanish Chronic Hepatitis B Registry (Ciberhep)

Journal of hepatology, 2016, Vol.64 (2), p.S324-S325

2016

Volltextzugriff (PDF)

LBP511 - Effectiveness and Safety of Sofosbuvir/Ledipasvir Treatment for Monoinfected Genotype 1 HCV Patients in Real-Life Clinical Practice: Results from Spanish Hepa-C Cohort

Journal of hepatology, 2016, Vol.64 (2), p.S217-S218

2016

Volltextzugriff (PDF)

218 TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN HEPATITIS C NATIVE LIVER VS. LIVER TRANSPLANT RECIPIENTS WITH RECURRENCE: DIAGNOSTIC PERFORMANCE AND PREDICTORS OF ADVANCED FIBROSIS

Journal of hepatology, 2008, Vol.48, p.S90-S90

2008

Volltextzugriff (PDF)

747 FAILURE OF LIVER STIFFNESS MEASUREMENT WITH FIBROSCAN: PREVALENCE AND DETERMINANTS

Journal of hepatology, 2008, Vol.48, p.S279-S279

2008

Volltextzugriff (PDF)

PIN6 CLINICAL BENEFITS AND COST SAVINGS FROM IMPLEMENTING A SIMPLIFIED STRATEGY FOR GLECAPREVIR/PIBRENTASVIR (G/P) 8-WEEK TREATMENT IN NON-CIRRHOTIC NAÃVE PATIENTS WITH HEPATITIS C. THE JUST SIMPLE STUDY (REAL CLINICAL PRACTICE IN SPAIN)

Value in health, 2020-05, Vol.23, p.S169-S169

2020

Volltextzugriff (PDF)

In situ expression of factor VII in the liver of patients withchronic hepatitis: Correlation with the severity of the liverdisease

Journal of hepatology, 2000, Vol.32, p.67-67

2000

Volltextzugriff (PDF)

Enfermedad celíaca y síndrome de Budd-Chiari: una asociación infrecuente

Gastroenterología y hepatología, 2002, Vol.25 (3), p.159-161

2002

Volltextzugriff (PDF)

Anosmia y ageusia inducidas por el interferón en la hepatitis crónica c

Gastroenterología y hepatología, 2001, Vol.24 (8), p.412-412

2001

Volltextzugriff (PDF)

Hepatotoxicidad crónica por fenitoína

Gastroenterología y hepatología, 2001, Vol.24 (8), p.412-413

2001

Volltextzugriff (PDF)

Environmental risk assessment of effluents as a whole emerging contaminant: Efficiency of alternative tertiary treatments for wastewater depuration

Water research (Oxford), 2017-08, Vol.119, p.136-149

2017

Volltextzugriff (PDF)

Fly ash lightweight material of the cellular concrete type using sol-gel and thermal treatment

Construction & building materials, 2019-05, Vol.206, p.512-518

2019

Volltextzugriff (PDF)

Combined AOPs for potential wastewater reuse or safe discharge based on multi-barrier treatment (microfiltration-H2O2/UV-catalytic wet peroxide oxidation)

Chemical engineering journal (Lausanne, Switzerland : 1996), 2015-06, Vol.270, p.80-90

2015

Volltextzugriff (PDF)

A single method to estimate the daily global solar radiation from monthly data

Atmospheric research, 2015-12, Vol.166, p.70-82

2015

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(46)

Sprache

Erscheinungsjahr

n.n

Thema

Gastroenterology And Hepatology
(15)
Science & Technology
(10)
Technology
(5)
Animals
(4)
Life Sciences & Biomedicine
(4)
Physical Sciences
(4)
Engineering
(3)
Care Management
(2)
Engineering, Environmental
(2)
Excited State Reaction
(2)
Gestión Asistencial
(2)
Heart Failure
(2)
Humans
(2)
Hypertension
(2)
Insuficiencia Cardiaca
(2)
Laser Excitation
(2)
Materials Science
(2)
Materials Science, Multidisciplinary
(2)
Mice
(2)
Nanoparticles
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Prevents HBV Reactivation with Tenofovir in Anti-HBC Positive Patients with Hematologic Malignancies Treated with Rituximab. Results Final Visit 18-Months (Preblin Study)

Clinical outcomes of patients delisted from the waiting list of liver transplantation after interferon-free antiviral therapy

P887 POST LIVER TRANSPLANTATION PROPHYLAXIS OF HEPATITIS B RECURRENCE WITH NUCLEOS(T)IDE ANALOG THERAPY FOLLOWING HEPATITIS B IMMUNOGLOBULIN DISCONTINUATION

Decreasing the Risk of HCC in Caucasian Chronic Hepatitis B Patients under NUCS: Results of the Spanish Chronic Hepatitis B Registry (Ciberhep)

Interferon (INF)-Free Antiviral Therapy in Cirrhotic Patients Infected with Hepatitis C on the Waiting List for Liver Transplantation. Efficacy and Impact on Delisting and Liver Function

P1040 TENOFOVIR FOR THE PROPHYLAXIS OF HBV REACTIVATION IN ANTI-HBC-POSITIVE PATIENTS WITH HEMATOLOGIC MALIGNANCIES TREATED WITH RITUXIMAB: PRELIMINARY RESULTS OF A RANDOMIZED STUDY (PREBLIN STUDY)

Effectiveness and Safety of Sofosbuvir/Ledipasvir Treatment for Monoinfected Genotype 1 HCV Patients in Real-Life Clinical Practice: Results from Spanish Hepa-C Cohort

P1058 LONG-TERM EFFICACY OF TENOFOVIR IN PREVIOUSLY TREATED AND NAIVE PATIENTS. RESULTS FROM THE SPANISH CHRONIC HEPATITIS B REGISTRY (CIBERHEP)

194 RISK-FACTORS ASSOCIATED WITH THE DEVELOPMENT OF CHRONIC REJECTION DURING ANTIVIRAL THERAPY OF POST-TRANSPLANT RECURRENT HEPATITIS C: A PROSPECTIVE STUDY

THU-139 - Prevents HBV Reactivation with Tenofovir in Anti-HBC Positive Patients with Hematologic Malignancies Treated with Rituximab. Results Final Visit 18-Months (Preblin Study)

THU-431 - Clinical outcomes of patients delisted from the waiting list of liver transplantation after interferon-free antiviral therapy

FRI-464 - Interferon (INF)-Free Antiviral Therapy in Cirrhotic Patients Infected with Hepatitis C on the Waiting List for Liver Transplantation. Efficacy and Impact on Delisting and Liver Function

THU-056 - Decreasing the Risk of HCC in Caucasian Chronic Hepatitis B Patients under NUCS: Results of the Spanish Chronic Hepatitis B Registry (Ciberhep)

LBP511 - Effectiveness and Safety of Sofosbuvir/Ledipasvir Treatment for Monoinfected Genotype 1 HCV Patients in Real-Life Clinical Practice: Results from Spanish Hepa-C Cohort

218 TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN HEPATITIS C NATIVE LIVER VS. LIVER TRANSPLANT RECIPIENTS WITH RECURRENCE: DIAGNOSTIC PERFORMANCE AND PREDICTORS OF ADVANCED FIBROSIS

747 FAILURE OF LIVER STIFFNESS MEASUREMENT WITH FIBROSCAN: PREVALENCE AND DETERMINANTS

PIN6 CLINICAL BENEFITS AND COST SAVINGS FROM IMPLEMENTING A SIMPLIFIED STRATEGY FOR GLECAPREVIR/PIBRENTASVIR (G/P) 8-WEEK TREATMENT IN NON-CIRRHOTIC NAÃVE PATIENTS WITH HEPATITIS C. THE JUST SIMPLE STUDY (REAL CLINICAL PRACTICE IN SPAIN)

In situ expression of factor VII in the liver of patients withchronic hepatitis: Correlation with the severity of the liverdisease

Enfermedad celíaca y síndrome de Budd-Chiari: una asociación infrecuente

Anosmia y ageusia inducidas por el interferón en la hepatitis crónica c

Hepatotoxicidad crónica por fenitoína

Environmental risk assessment of effluents as a whole emerging contaminant: Efficiency of alternative tertiary treatments for wastewater depuration

Fly ash lightweight material of the cellular concrete type using sol-gel and thermal treatment

Combined AOPs for potential wastewater reuse or safe discharge based on multi-barrier treatment (microfiltration-H2O2/UV-catalytic wet peroxide oxidation)

A single method to estimate the daily global solar radiation from monthly data

Suchergebnisse filtern